Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $16.1200 (4.54%) ($15.0300 - $16.3200) on Wed. Sep. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.43% (three month average) | RSI | 63 | Latest Price | $16.1200(4.54%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -0.4% a day on average for past five trading days. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) IFRA(27%) QQQ(26%) XLC(26%) IBB(24%) SDY(24%) | Factors Impacting SONN price | SONN will decline at least -2.715% in a week (0% probabilities). VCSH(-34%) TLT(-26%) LQD(-26%) CEMB(-25%) VCIT(-19%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.715% (StdDev 5.43%) | Hourly BBV | 0 () | Intraday Trend | 7.3% | | | |
|
5 Day Moving Average | $15.45(4.34%) | 10 Day Moving Average | $15.7(2.68%) | 20 Day Moving Average | $15.31(5.29%) | To recent high | -43.6% | To recent low | 21.6% | Market Cap | $148m | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |